Survival Outcomes in Patients with Catheter-Related Bloodstream Infection
Main Article Content
Abstract
Background: Catheter-related bloodstream infection (CRBSI) is one of the most serious complications related to central venous catheter use and is associated with substantial morbidity and mortality. This retrospective cohort study aimed to identify prognostic factors associated with 90-day mortality among patients with CRBSI at Hospital Pakar Universiti Sains Malaysia (HPUSM).
Methods: This retrospective cohort study included 181 patients diagnosed with CRBSI at HPUSM between 2018 and 2022. Time zero was defined as the date of CRBSI diagnosis, while the event of interest was all-cause mortality within 90 days of diagnosis. Cox proportional hazards regression analysis was used to identify factors associated with 90-day mortality.
Results: Of the 181 included patients, 64 (35.4%) died within 90 days of CRBSI diagnosis, while 117 (64.6%) were censored. Factors independently associated with higher mortality risk were sepsis or septic shock (adjusted hazard ratio [aHR] 5.95; 95% confidence interval [CI]: 2.88, 12.28), mechanical ventilation (aHR 5.94; 95% CI: 3.29, 10.71), shorter length of hospital stay (aHR 1.13; 95% CI: 1.10, 1.17), and female sex (aHR 2.71; 95% CI: 1.60, 4.58). Infection caused by Gram-negative organisms was associated with lower mortality risk (aHR 0.31; 95% CI: 0.18, 0.55).
Conclusion: Several clinical and microbiological factors were independently associated with 90-day mortality among patients with CRBSI. These findings may be useful for risk stratification and clinical management of patients with CRBSI.
Article Details
Issue
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
1. İnce N, Yekenkurul D, Çalişkan E, Gürbüz AR, Yener S. Investigation of the factors associated with mortality in catheter-related bloodstream infections: five-year observation. Duzce Med J. 2020;22(3):149–153. https://doi.org/10.18678/dtfd.746887
2. Chaves F, Garnacho-Montero J, Del Pozo JL, Bouza E, Capdevila JA, de Cueto M, et al. Diagnosis and treatment of catheter-related bloodstream infection: clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC). Med Intensiva. 2018;42(1):5–36. https://doi.org/10.1016/j.medin.2017.09.012
3. Turken M, Kilinc Toker A, Zincirlioglu C, Kose S. Risk factors and incidence of catheter-related bloodstream infections in a tertiary hospital ICU. EJMI. 2019;3(1):32–36. https://doi.org/10.14744/ejmi.2018.0001
4. Shahar S, Mustafar R, Kamaruzaman L, Periyasamy P, Pau KB, Ramli R. Catheter-related bloodstream infections and catheter colonization among haemodialysis patients: prevalence, risk factors, and outcomes. Int J Nephrol. 2021;2021(1):5562690. https://doi.org/10.1155/2021/5562690
5. Inan Sarıkaya R, Karaşahin O. Prognostic factors for mortality in catheter-related bloodstream infections among hemodialysis patients: a prospective single-center study. Medicina. 2025;61(12):2205. https://doi.org/10.3390/medicina61122205
6. Calderwood MS. Intravascular non-hemodialysis catheter-related infection: clinical manifestations and diagnosis. [Internet]. Waltham (MA): UpToDate; 2023. [Retrieved 2023 Oct 06]. Available at: https://www.uptodate.com/contents/intravascular-non-hemodialysis-catheter-related-infection-clinical-manifestations-and-diagnosis
7. Zhang Y, Wang Y, Sheng Z, Wang Q, Shi D, Xu S, et al. Incidence rate, pathogens and economic burden of catheter-related bloodstream infection: a single-center, retrospective case-control study. Infect Drug Resist. 2023;16:3551–3560. https://doi.org/10.2147/IDR.S406681
8. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45. https://doi.org/10.1086/599376
9. Gahlot R, Nigam C, Kumar V, Yadav G, Anupurba S. Catheter-related bloodstream infections. Int J Crit Illn Inj Sci. 2014;4(2):162–167. https://doi.org/10.4103/2229-5151.134184
10. Ngo Bell EC, Chapon V, Bessede E, Meriglier E, Issa N, Domblides C, et al. Central venous catheter-related bloodstream infections: epidemiology and risk factors for hematogenous complications. Infect Dis Now. 2024;54(3):104859. https://doi.org/10.1016/j.idnow.2024.104859
11. Saliba P, Hornero A, Cuervo G, Grau I, Jimenez E, García D, et al. Mortality risk factors among non-ICU patients with nosocomial vascular catheter-related bloodstream infections: a prospective cohort study. J Hosp Infect. 2018;99(1):48–54. https://doi.org/10.1016/j.jhin.2017.11.002
12. Zhong Y, Zhou L, Liu X, Deng L, Wu R, Xia Z, et al. Incidence, risk factors, and attributable mortality of catheter-related bloodstream infections in the intensive care unit after suspected catheters infection: a retrospective 10-year cohort study. Infect Dis Ther. 2021;10(2):985–999. https://doi.org/10.1007/s40121-021-00429-3
13. Su TY, Ye JJ, Hsu PC, Wu HF, Chia JH, Lee MH. Clinical characteristics and risk factors for mortality in cefepime-resistant Pseudomonas aeruginosa bacteremia. J Microbiol Immunol Infect. 2015;48(2):175–182. https://doi.org/10.1016/j.jmii.2013.07.009
14. Calo F, Retamar P, Perez-Crespo PMM, Lanz-Garcia J, Sousa A, Goikoetxea J, et al. Catheter-related bloodstream infections: predictive factors for Gram-negative bacteria aetiology and 30-day mortality in a multicentre prospective cohort. J Antimicrob Chemother. 2020;75(10):3056–3061. https://doi.org/10.1093/jac/dkaa262
15. Lee Y, Lee YT, Wang YC, Chen CT, Sun JR, Liu CP, et al. Risk of mortality of catheter-related bloodstream infections caused by Acinetobacter species: is early removal of the catheters associated with a better survival outcome? J Intensive Care Med. 2018;33(6):361–369. https://doi.org/10.1177/0885066616677710
16. Kalil A, Bailey KL. Septic shock. [Internet]. Newark (NJ): Medscape; 2025. [Retrieved 2025 May 26]. Available at: https://emedicine.medscape.com/article/168402-overview#a3
17. Rosenthal VD, Yin R, Lu Y, Rodrigues C, Myatra SN, Kharbanda M, et al. The impact of healthcare-associated infections on mortality in ICU: a prospective study in Asia, Africa, Eastern Europe, Latin America, and the Middle East. Am J Infect Control. 2023;51(6):675–682. https://doi.org/10.1016/j.ajic.2022.08.024
18. Ismaeil T, Almutairi J, Alshaikh R, Althobaiti Z, Ismaiel Y, Othman F. Survival of mechanically ventilated patients admitted to intensive care units: results from a tertiary care center between 2016–2018. Saudi Med J. 2019;40(8):781–788. https://doi.org/10.15537/smj.2019.8.24447
19. Han TS, Murray P, Robin J, Wilkinson P, Fluck D, Fry CH. Evaluation of the association of length of stay in hospital and outcomes. Int J Qual Health Care. 2022;34(2):mzab160. https://doi.org/10.1093/intqhc/mzab160
20. Çepni Kütahya E, Ugur O, Tomruk M, Demirel S, Demirel F, Balasar B, et al. The effect of risk factors on mortality in central line associated bloodstream infections developing in the intensive care unit. Chron Precis Med Res. 2024;5(2):84–88. https://doi.org/10.5281/zenodo.12805654
21. Cheewinmethasiri J, Chittawatanarat K, Chandacham K, Jirapongchareonlap T, Chotirosniramit N. Microbiology, risk factors and mortality of patients with intravenous catheter related blood stream infections in the surgical intensive care unit: a five-year, concurrent, case-controlled study. J Med Assoc Thai. 2014;97(Suppl 1):S93–S101.
22. Shields CA, Wang X, Cornelius DC. Sex differences in cardiovascular response to sepsis. Am J Physiol Cell Physiol. 2022;324(2):C458–C466. https://doi.org/10.1152/ajpcell.00134.2022
23. Oliva A, Stefani S, Venditti M, Di Domenico EG. Biofilm-related infections in Gram-positive bacteria and the potential role of the long-acting agent dalbavancin. Front Microbiol. 2021;12:749685. https://doi.org/10.3389/fmicb.2021.749685
24. Lendak D, Puerta-Alcalde P, Moreno-García E, Chumbita M, García-Pouton N, Cardozo C, et al. Changing epidemiology of catheter-related bloodstream infections in neutropenic oncohematological patients. PLoS One. 2021;16(4):e0251010. https://doi.org/10.1371/journal.pone.0251010
25. Badia-Cebada L, Peñafiel J, López-Contreras J, Pomar V, Martínez JA, Santana G, et al. Decreased mortality among patients with catheter-related bloodstream infections at Catalan hospitals (2010–2019). J Hosp Infect. 2022;126:70–77. https://doi.org/10.1016/j.jhin.2022.05.009